EA005080B1 - Способ получения сферических агломератов телитромицина и их применение для приготовления лекарственных форм - Google Patents
Способ получения сферических агломератов телитромицина и их применение для приготовления лекарственных форм Download PDFInfo
- Publication number
- EA005080B1 EA005080B1 EA200200294A EA200200294A EA005080B1 EA 005080 B1 EA005080 B1 EA 005080B1 EA 200200294 A EA200200294 A EA 200200294A EA 200200294 A EA200200294 A EA 200200294A EA 005080 B1 EA005080 B1 EA 005080B1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- telithromycin
- preparation
- crystallization
- spherical
- acetone
- Prior art date
Links
- LJVAJPDWBABPEJ-PNUFFHFMSA-N telithromycin Chemical class O([C@@H]1[C@@H](C)C(=O)[C@@H](C)C(=O)O[C@@H]([C@]2(OC(=O)N(CCCCN3C=C(N=C3)C=3C=NC=CC=3)[C@@H]2[C@@H](C)C(=O)[C@H](C)C[C@@]1(C)OC)C)CC)[C@@H]1O[C@H](C)C[C@H](N(C)C)[C@H]1O LJVAJPDWBABPEJ-PNUFFHFMSA-N 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims abstract description 12
- 238000002360 preparation method Methods 0.000 title abstract description 6
- 238000004519 manufacturing process Methods 0.000 title abstract description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 20
- 229960003250 telithromycin Drugs 0.000 claims abstract description 18
- 238000002425 crystallisation Methods 0.000 claims abstract description 9
- 230000008025 crystallization Effects 0.000 claims abstract description 9
- 239000000725 suspension Substances 0.000 claims abstract description 8
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 claims abstract description 6
- 239000013078 crystal Substances 0.000 claims abstract description 6
- 229920000642 polymer Polymers 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000000576 coating method Methods 0.000 claims description 3
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003094 microcapsule Substances 0.000 abstract description 3
- XCAUINMIESBTBL-UHFFFAOYSA-N lead(ii) sulfide Chemical group [Pb]=S XCAUINMIESBTBL-UHFFFAOYSA-N 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000002245 particle Substances 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 238000005354 coacervation Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 238000012695 Interfacial polymerization Methods 0.000 description 1
- 238000005054 agglomeration Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 238000009529 body temperature measurement Methods 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- ORTFAQDWJHRMNX-UHFFFAOYSA-N hydroxidooxidocarbon(.) Chemical group O[C]=O ORTFAQDWJHRMNX-UHFFFAOYSA-N 0.000 description 1
- 125000001841 imino group Chemical group [H]N=* 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 229920002959 polymer blend Polymers 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 239000012798 spherical particle Substances 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9910810A FR2797875B1 (fr) | 1999-08-26 | 1999-08-26 | Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques |
| PCT/FR2000/002393 WO2001014393A2 (fr) | 1999-08-26 | 2000-08-28 | Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA200200294A1 EA200200294A1 (ru) | 2002-08-29 |
| EA005080B1 true EA005080B1 (ru) | 2004-10-28 |
Family
ID=9549351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA200200294A EA005080B1 (ru) | 1999-08-26 | 2000-08-28 | Способ получения сферических агломератов телитромицина и их применение для приготовления лекарственных форм |
Country Status (34)
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9902202D0 (sv) * | 1999-06-10 | 1999-06-10 | Astra Ab | Production of aggregates |
| FR2821747B1 (fr) * | 2001-03-09 | 2004-07-02 | Ethypharm Lab Prod Ethiques | Suspension de telithromycine a gout masque |
| BR0215806A (pt) * | 2002-07-19 | 2005-04-26 | Aventis Pharma Sa | Composição oral de telitromicina com paladar mascarado |
| US20040013737A1 (en) * | 2002-07-19 | 2004-01-22 | Philippe Becourt | Taste masked oral composition of telithromycin |
| WO2004009059A1 (en) * | 2002-07-19 | 2004-01-29 | Aventis Pharma S.A. | Taste masked oral composition of telithromycin |
| CA2516733C (en) * | 2003-02-21 | 2011-09-27 | The University Of Bath | Process for the production of particles |
| US20050014706A1 (en) * | 2003-07-14 | 2005-01-20 | Kanakeshwari Falzari | Method of treating tuberculosis |
| WO2007039914A2 (en) * | 2005-10-06 | 2007-04-12 | Alembic Limited | Novel polymorphs of telithromycin |
| US20090075917A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched telithromycin |
| KR101324862B1 (ko) * | 2011-07-12 | 2013-11-01 | (주)에이에스텍 | 클로피도그렐 황산수소염의 구형 입자, 이를 포함하는 약학적 조성물 및 이의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3468336D1 (en) * | 1983-06-22 | 1988-02-11 | Univ Ohio State Res Found | Small particle formation |
| JPH02227130A (ja) * | 1989-02-28 | 1990-09-10 | Taisho Pharmaceut Co Ltd | 球形微小凍結粒子の製造法 |
| FR2719587B1 (fr) * | 1994-05-03 | 1996-07-12 | Roussel Uclaf | Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments. |
-
1999
- 1999-08-26 FR FR9910810A patent/FR2797875B1/fr not_active Expired - Fee Related
-
2000
- 2000-08-02 TW TW089115526A patent/TWI272949B/zh not_active IP Right Cessation
- 2000-08-18 CO CO00062195A patent/CO5190666A1/es active IP Right Grant
- 2000-08-25 AR ARP000104426A patent/AR025398A1/es unknown
- 2000-08-28 EA EA200200294A patent/EA005080B1/ru not_active IP Right Cessation
- 2000-08-28 TR TR2002/00506T patent/TR200200506T2/xx unknown
- 2000-08-28 IL IL14812800A patent/IL148128A0/xx active IP Right Grant
- 2000-08-28 US US10/049,874 patent/US6825218B1/en not_active Expired - Fee Related
- 2000-08-28 AT AT00958756T patent/ATE255590T1/de active
- 2000-08-28 KR KR1020027002404A patent/KR100718222B1/ko not_active Expired - Fee Related
- 2000-08-28 SI SI200030287T patent/SI1212336T1/xx unknown
- 2000-08-28 BR BRPI0013569-0A patent/BR0013569B1/pt not_active IP Right Cessation
- 2000-08-28 CN CNB008120943A patent/CN1183151C/zh not_active Expired - Fee Related
- 2000-08-28 ES ES00958756T patent/ES2209970T3/es not_active Expired - Lifetime
- 2000-08-28 UA UA2002032354A patent/UA73523C2/uk unknown
- 2000-08-28 HU HU0202842A patent/HU229075B1/hu not_active IP Right Cessation
- 2000-08-28 HR HR20020167A patent/HRP20020167B1/xx not_active IP Right Cessation
- 2000-08-28 WO PCT/FR2000/002393 patent/WO2001014393A2/fr not_active Ceased
- 2000-08-28 DK DK00958756T patent/DK1212336T3/da active
- 2000-08-28 PL PL353137A patent/PL204100B1/pl unknown
- 2000-08-28 ME MEP-2008-201A patent/ME00112B/me unknown
- 2000-08-28 CZ CZ2002594A patent/CZ2002594A3/cs unknown
- 2000-08-28 RS YUP-132/02A patent/RS50433B/sr unknown
- 2000-08-28 PT PT00958756T patent/PT1212336E/pt unknown
- 2000-08-28 HK HK03101349.3A patent/HK1049167B/zh not_active IP Right Cessation
- 2000-08-28 MX MXPA02001988A patent/MXPA02001988A/es active IP Right Grant
- 2000-08-28 EP EP00958756A patent/EP1212336B1/fr not_active Expired - Lifetime
- 2000-08-28 JP JP2001518723A patent/JP4871467B2/ja not_active Expired - Fee Related
- 2000-08-28 ME MEP-201/08A patent/MEP20108A/xx unknown
- 2000-08-28 CA CA2382497A patent/CA2382497C/fr not_active Expired - Fee Related
- 2000-08-28 DE DE60006976T patent/DE60006976T2/de not_active Expired - Lifetime
- 2000-08-28 AU AU70181/00A patent/AU774385B2/en not_active Ceased
- 2000-08-28 SK SK253-2002A patent/SK287588B6/sk not_active IP Right Cessation
-
2002
- 2002-02-12 IL IL148128A patent/IL148128A/en not_active IP Right Cessation
- 2002-02-26 ZA ZA200201599A patent/ZA200201599B/en unknown
- 2002-02-26 NO NO20020926A patent/NO322622B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR900000212B1 (ko) | 즉석 균질마이크로 캅셀 현탁액의 제조방법 | |
| JP4129995B2 (ja) | 水性媒体に迅速に懸濁する医薬組成物 | |
| CA2169376C (en) | Procedure for encapsulating nsaids | |
| US8658212B2 (en) | Pharmaceutical composition containing fenofibrate and method for the preparation thereof | |
| JPS62103013A (ja) | 薬物のマイクロカプセル封入方法 | |
| CN104650091B (zh) | 替格瑞洛的微粉化及其晶型，以及制备方法和药物应用 | |
| JPH0288520A (ja) | ミクロ−粒子及び／又はナノ−粒子から成る新規固体状の多孔性、単位投与製剤、及びその製造方法 | |
| EP0164959A2 (en) | Pharmaceutical composition in sustained release unit dose form and process for its preparation | |
| DE69615400T2 (de) | 5-asa enthaltendes orales arzneimittel mit modifizierter freisetzung sowie verfahren zur behandlung von darmerkrankungen | |
| EA005080B1 (ru) | Способ получения сферических агломератов телитромицина и их применение для приготовления лекарственных форм | |
| KR100877628B1 (ko) | 지용성 물질을 포함하는 과립형 물질 및 제조방법 | |
| JPH03118335A (ja) | 風味マスキングされたマイクロカプセル化非ステロイド系抗炎症水不溶性薬剤 | |
| US4832955A (en) | Controlled release potassium chloride composition | |
| DE10202019A1 (de) | Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II | |
| Firke et al. | Floating Microspheres as Gastro-Retentive Drug Delivery System: A Review | |
| PL94119B1 (enExample) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM AZ BY KZ KG MD TJ TM |
|
| MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): RU |